# 12-month Study of AMG 073 in Renal Osteodystrophy

> **NCT00527085** · PHASE2 · COMPLETED · sponsor: **Amgen** · enrollment: 45 (estimated)

## Conditions studied

- Renal Osteodystrophy

## Interventions

- **DRUG:** AMG 073
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00527085
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-10
- **Primary completion:** 2003-08
- **Final completion:** 2003-08
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2013-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00527085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00527085, "12-month Study of AMG 073 in Renal Osteodystrophy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00527085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*